For the Quarter Ending December 2025
Salbutamol Sulphate Prices in North America
- In the United States, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q4 2025, driven by increased production costs.
- Salbutamol Sulphate production costs increased due to a 3.0% year-over-year PPI rise in November 2025.
- Demand for Salbutamol Sulphate expanded in Q4 2025, supported by FDA approvals in the respiratory drug market.
- Industrial production increased by 2.0% year-over-year in December 2025, indicating stable supply chains.
- Consumer Price Index rose 2.7% year-over-year in December 2025, increasing operational and labor expenses.
- North American chemical producers benefited from low-cost feedstock in November 2025, mitigating cost pressures.
- Global trade growth decelerated sharply in the final months of 2025 due to tariffs.
- The unemployment rate of 4.4% in December 2025 indicated a tight labor market, increasing labor costs.
Why did the price of Salbutamol Sulphate change in December 2025 in North America?
- Rising input costs, with PPI up 3.0% year-over-year in November 2025, elevated production expenses.
- Strong demand drivers, including FDA approvals for respiratory drugs in Q4 2025, supported market expansion.
- General inflation, with CPI rising 2.7% year-over-year in December 2025, increased overall operational costs.
Salbutamol Sulphate Prices in APAC
- In China, the Salbutamol Sulphate Price Index fell in Q4 2025, driven by declining production costs.
- Production costs decreased as the Producer Price Index declined by -1.9% year-on-year in December 2025.
- Persistent overcapacity in China's chemical sector in October 2025 pressured chemical input prices downward.
- Demand for Salbutamol Sulphate was supported by robust pharmaceutical industry growth in China during 2025.
- Industrial Production increased by 5.2% year-on-year in December 2025, indicating a healthy manufacturing environment.
- Domestic consumer demand remained sluggish in China during Q4 2025, with retail sales up 0.9% year-on-year.
- Healthcare industry financing showed strong recovery in Q4 2025, supporting pharmaceutical sector investment.
- China's Manufacturing Index expanded in December 2025, reflecting broader industrial sector growth.
Why did the price of Salbutamol Sulphate change in December 2025 in APAC?
- Producer Price Index declined by -1.9% year-on-year in December 2025, reducing Salbutamol Sulphate production costs.
- Persistent overcapacity in China's chemical sector in October 2025 created downward pressure on input prices.
- Sluggish domestic consumer demand in Q4 2025, with retail sales up 0.9% year-on-year, tempered overall demand.
Salbutamol Sulphate Prices in Europe
- In Germany, the Salbutamol Sulphate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Salbutamol Sulphate production costs decreased in December 2025 as the Producer Price Index declined by 2.5% year-over-year.
- Demand for Salbutamol Sulphate was supported by an increase in German pharmaceuticals output during 2025.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in overall economic activity.
- Consumer Price Index rose by 1.8% year-over-year in December 2025, affecting operational expenses.
- Industrial production grew by 0.8% in October 2025, providing a stable supply chain; retail sales grew 1.1% in November 2025.
- Unemployment was 6.2% in December 2025, while consumer confidence remained low at -17.5.
- European natural gas prices stabilized in Q4 2025, with slight easing observed in November.
- The Salbutamol Sulphate Price Forecast suggests continued pressure from competitive foreign imports in Q4 2025.
Why did the price of Salbutamol Sulphate change in December 2025 in Europe?
- Producer Price Index declined by 2.5% in December 2025, reducing Salbutamol Sulphate input costs.
- Increased competitive pressure from abroad led German chemical companies to adjust prices downwards in October 2025.
- Weak domestic and export orders for German chemical industry in Q4 2025 impacted demand.
For the Quarter Ending September 2025
North America
- In United States, the Salbutamol Sulphate Price Index remained stable in Q3 2025, influenced by mixed macroeconomic signals.
- Production costs rose due to a 2.6% year-over-year PPI increase in August 2025, reflecting higher input expenses.
- Demand outlook supported by 5.42% retail sales rise and 4.3% unemployment rate in September 2025.
- Declining consumer confidence to 94.2 in September 2025 suggested potential future constraints on healthcare spending.
- Chemical manufacturing activity contracted in Q3 2025, despite a marginal 0.1% industrial production increase in September 2025.
- Feedstock benzene costs strengthened in July and August 2025, elevating phenol production expenses for Salbutamol Sulphate.
- US pharmaceutical exports decreased year-on-year in July 2025, while imports increased, expanding the sector's trade deficit.
- Salbutamol Sulphate price forecast stable, with 3.0% CPI in September 2025 balanced by easing phenol prices.
Why did the price of Salbutamol Sulphate change in September 2025 in North America?
- Phenol prices eased in September 2025 due to elevated inventories, moderating Salbutamol Sulphate production costs.
- A 3.0% year-over-year CPI increase in September 2025 indicated general inflationary pressure on operational expenses.
- Robust retail sales, up 5.42% year-over-year in September 2025, supported consumer affordability.
APAC
- In China, the Salbutamol Sulphate Price Index fell quarter-over-quarter in Q3 2025, due to deflationary pressures and persistent oversupply.
- Salbutamol Sulphate production costs faced downward pressure in September 2025, as producer prices declined 2.3% year-over-year.
- Demand for Salbutamol Sulphate is supported by 3.0% retail sales growth in September 2025 and expanding healthcare.
- China's pharmaceutical market saw robust growth in 2025, driven by an aging population and rising chronic diseases.
- Petrochemical feedstock prices for Salbutamol Sulphate held steady throughout Q3 2025 amid global overcapacity.
- The Manufacturing Index contracted in September 2025, reflecting reduced industrial activity affecting supply chains.
- Industrial production, however, expanded 6.5% year-over-year in September 2025, indicating growth in manufacturing.
- New export orders for China's manufacturing sector strengthened in September 2025, increasing after several months.
- Consumer confidence remained low at 89.6 in September 2025, with 5.2% unemployment, dampening spending.
- Government policy in September 2025 aims to optimize capacity and foster high-value specialty chemicals.
Why did the price of Salbutamol Sulphate change in September 2025 in APAC?
- Consumer Price Index declined 0.3% in September 2025, indicating deflationary pressures and price erosion.
- Producer Price Index fell 2.3% in September 2025, suggesting lower input costs for production.
- Low consumer confidence at 89.6 and 5.2% unemployment dampened pharmaceutical demand.
Europe
- In Germany, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by elevated raw material and operational costs.
- Salbutamol Sulphate production costs faced upward pressure from a 2.4% CPI increase in September 2025, impacting operations.
- Producer prices fell 1.7% in September 2025 due to lower energy costs, partially offsetting production burdens.
- Demand for pharmaceutical products, including Salbutamol Sulphate, strengthened in Germany during Q3 2025.
- The Manufacturing Index contracted in Q3 2025, indicating a broader slowdown affecting Salbutamol Sulphate supply chains.
- German industrial production declined 1.0% in September 2025, indirectly impacting non-API components and logistics.
- Retail sales increased 0.2% in September 2025, suggesting a stable consumer economy supporting healthcare spending.
- The unemployment rate remained stable at 6.3% in September 2025, potentially straining healthcare access and funding.
- European natural gas spot prices eased in Q3 2025, reducing energy feedstock costs for Salbutamol Sulphate manufacturing.
Why did the price of Salbutamol Sulphate change in September 2025 in Europe?
- Elevated raw material costs and 2.4% CPI increase in September 2025 pressured Salbutamol Sulphate prices.
- Easing natural gas prices and 1.7% PPI decrease in September 2025 partially offset production costs.
- Strengthening pharmaceutical demand in Q3 2025 supported Salbutamol Sulphate prices despite industrial weakness.
